Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
Recruiting · NCT06674265 · Registry updated 2025-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma | Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2025-04-09 | NCT06674265 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Iran University of Medical Sciences | 7 |
| Marzieh Ebrahimi | 2 |
| Royan Institute | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rasoul Akram Hospital | Tehran | Iran | 1 |